ANSS Financial Statements & Analysis
Complete financial statements for ANSS including income statement, balance sheet, and cash flow statement. Analyze ANSS's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
61
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
12.1% ↑
Net Income
15.0% ↑
Gross Margin
1.1% ↑
Operating Margin
2.3% ↑
Balance Sheet
Current Ratio
30.5% ↑
Debt to Equity
-12.8% ↑
Asset Turnover
2.0% ↑
Cash Flow
Operating Cash Flow
11.0% ↑
Net Cash Flow
138.6% ↑
Free Cash Flow
8.7% ↑
Cash Flow to Debt
12.7% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 2.27B | 2.54B | 12.1% | |
| Gross Profit | 2.00B | 2.26B | 13.3% | |
| Operating Income | 626.13M | 717.89M | 14.7% | |
| Net Income | 500.41M | 575.69M | 15.0% | |
| EPS | 5.76 | 6.59 | 14.4% | |
| EBITDA | 758.64M | 908.56M | 19.8% | |
| Gross Margin | 88.05% | 89.00% | 1.1% | |
| Operating Margin | 27.58% | 28.21% | 2.3% | |
| Net Income Margin | 22.05% | 22.62% | 2.6% | |
| R&D Expenses | 494.87M | 528.01M | 6.7% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 2.54B | 2.27B | 2.07B | 1.91B | 1.68B |
| Gross Profit | 2.26B | 2.00B | 1.81B | 1.65B | 1.46B |
| Operating Income | 717.89M | 626.13M | 592.66M | 513.27M | 496.36M |
| Net Income | 575.69M | 500.41M | 523.71M | 454.63M | 433.89M |
| EPS | 6.59 | 5.76 | 6.02 | 5.22 | 5.05 |
| EBITDA | 908.56M | 758.64M | 707.22M | 620.14M | 581.63M |
| Gross Margin | 89.00% | 88.05% | 87.87% | 86.47% | 86.60% |
| Operating Margin | 28.21% | 27.58% | 28.69% | 26.92% | 29.52% |
| Net Income Margin | 22.62% | 22.05% | 25.35% | 23.84% | 25.81% |
| R&D Expenses | 528.01M | 494.87M | 433.66M | 404.87M | 355.37M |